Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
228
datasets available to search
ShareScore release 0.9.0
Dataset results
228 results for “Immunotherapy targets”
Efficacy of Target - Immunotherapy and XELOX Chemotherapy for Advanced HCC
ClinicalTrials.gov study NCT06818097. IPD Sharing: NO. Countries: 1. Publications: 0.
Immunotherapy Using CAR T-cells to Target CD19 for Relapsed/Refractory CD19+ Primary CNS Lymphoma
ClinicalTrials.gov study NCT04443829. IPD Sharing: NO. Countries: 1. Publications: 0.
Icaritin Soft Capsules+TACE+Immunotherapy+Targeted Therapy Versus TACE+Immunotherapy+Targeted Therapy for Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06896396. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLM
ClinicalTrials.gov study NCT07381309. IPD Sharing: NO. Countries: 1. Publications: 0.
Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)
ClinicalTrials.gov study NCT06842407. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Immunotherapy Targeting Sarcomas
ClinicalTrials.gov study NCT04433221. IPD Sharing: NO. Countries: 1. Publications: 0.
PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT06755775. IPD Sharing: NO. Countries: 1. Publications: 0.
Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer
ClinicalTrials.gov study NCT06992583. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess CD19-targeted Immunotherapy T Cells in Patients With Relapsed or Refractory CD19+ B Cell Leukemia
ClinicalTrials.gov study NCT02672501. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1
ClinicalTrials.gov study NCT02840058. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06540508. IPD Sharing: NO. Countries: 1. Publications: 0.
Immunotherapy Based on Antigen-specific Immune Effector Cells Targeting Neurofibromatosis or Schwannomatosis
ClinicalTrials.gov study NCT04085159. IPD Sharing: NO. Countries: 1. Publications: 0.
Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC
ClinicalTrials.gov study NCT05549466. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
ClinicalTrials.gov study NCT05253495. IPD Sharing: NO. Countries: 1. Publications: 0.
GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma
ClinicalTrials.gov study NCT05215665. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies
ClinicalTrials.gov study NCT06690281. IPD Sharing: YES. Countries: 1. Publications: 0.
MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma
ClinicalTrials.gov study NCT07029776. IPD Sharing: NO. Countries: 1. Publications: 0.
Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT)
ClinicalTrials.gov study NCT02118415. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR-T Cell Immunotherapy for HCC Targeting GPC3
ClinicalTrials.gov study NCT02723942. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04714827. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.